sorafenib has been researched along with lactose in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (lactose) | Trials (lactose) | Recent Studies (post-2010) (lactose) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 12,201 | 446 | 3,106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, XC; Guo, Y; Huang, D; Ren, W; Yao, X; Yin, YF; Zhang, Q; Zhang, S; Zhang, X; Zhong, T | 1 |
1 other study(ies) available for sorafenib and lactose
| Article | Year |
|---|---|
Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Lactose; Male; Methylcellulose; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Niacinamide; Phenylurea Compounds; Phosphatidylethanolamines; Polyethylene Glycols; Polymers; Random Allocation; Rats; Rats, Sprague-Dawley; Sorafenib; Tumor Burden | 2017 |